v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 3,828 $ 558 $ 9,394 $ 1,474
Operating expenses:        
Research and development 17,674 15,931 47,039 43,968
General and administrative 5,151 5,016 15,433 15,077
Total operating expenses 22,825 20,947 62,472 59,045
Loss from operations (18,997) (20,389) (53,078) (57,571)
Other (expense) income, net (489) 596 (830) 1,862
Net loss applicable to common stockholders $ (19,486) $ (19,793) $ (53,908) $ (55,709)
Net loss per share applicable to common stockholders - basic and diluted $ (0.43) $ (0.47) $ (1.19) $ (1.42)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 45,781,638 42,439,338 45,137,331 39,324,751

Source